Quick Answer
Lexeo Therapeutics, Inc. reported Total Revenue of $654.0 thousand for the year ending 2022.
- This data is from Lexeo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2024.
- XBRL data for this metric is available from 2022 to 2022 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $531.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: